Synthesis and human carbonic anhydrase I, II, VA, and XII inhibition with novel amino acid–sulphonamide conjugates

References

• Fukutake T, Wada K, Liu GC, et al. Striking effects of a titania support on the low-temperature activities of Ir catalysts for the dehydrogenative synthesis of benzimidazole and indole. Catal Today 2018;303:235–40.
   Web of Science ®Google Scholar
• Tacic A, Nikolic V, Nikolic L, Savic I. Antimicrobial sulfonamide drugs. Adv Technol 2017;6:58–71.
   Google Scholar
• (a) Hu Z, Awakawa T, Ma Z, Abe I. Aminoacyl sulfonamide assembly in SB-203208 biosynthesis. Nat Commun 2019;10:184. (b) Scozzafava A, Owa T, Mastrolorenzo A, Supuran C. C. Anticancer and antiviral sulfonamides. Curr Med Chem 2003;10:925–53.
   PubMed Web of Science ®Google Scholar
• (a) Capasso C, Supuran CT. Dihydropteroate synthase (sulfonamides) and dihydrofolate reductase inhibitors. In: Bonev BB, Brown NM, eds. Bacterial resistance to antibiotics – from molecules to man. London: John Wiley & Sons Ltd; 2020:163–72. (b) Capasso C, Supuran CT. Bacterial carbonic anhydrases. In Supuran CT, Capasso C, eds. Zinc enzyme inhibitors – enzymes from microorganisms. Vol. 22. New York (NY): Springer International Publishing; 2017:135–52.
   Google Scholar
• Supuran CT, Alterio V, Di Fiore A, et al. Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one. Med Res Rev 2018;38:1799–836.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2018;27:963–70.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature Rev Drug Discov 2008;7:168–81. (b) Supuran CT. The management of glaucoma and macular degeneration. Expert Opin Ther Pat 2019;29:745–7. (c) Supuran CT. Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review. Expert Opin Ther Pat 2019; 29:761–7.
   PubMed Web of Science ®Google Scholar
• (a) Patel TS, Vanparia SF, Patel UH, et al. Novel 2,3-disubstituted quinazoline-4(3H)-one molecules derived from amino acid linked sulphonamide as a potent malarial antifolates for DHFR inhibition. Eur J Med Chem 2017;129:251–65. (b) Scozzafava A, Menabuoni L, Mincione F, Supuran CT. Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties. J Med Chem 2002;45:1466–76.
   PubMed Web of Science ®Google Scholar
• Chinthakindi PK, Benediktsdottir A, Ibrahim A, et al. Synthesis of sulfonimidamide-based amino acid building blocks with orthogonal protecting groups. Eur J Org Chem 2019;2019:1045–57.
   Web of Science ®Google Scholar
• Meleddu R, Distinto S, Cottiglia F, et al. Tuning the dual inhibition of carbonic anhydrase and cyclooxygenase by dihydrothiazole benzensulfonamides. ACS Med Chem Lett 2018;9:1045–50.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? J Enzyme Inhib Med Chem 2018;33:485–95.
   PubMed Web of Science ®Google Scholar
• Bai Q, Tang J, Wang H. Functionalization of sulfonamide-containing peptides through late-stage palladium-catalyzed C(sp 3) –H arylation. Org Lett 2019;21:5858–61.
   PubMed Web of Science ®Google Scholar
• Chiaramonte N, Romanelli MN, Teodori E, Supuran CT. Amino acids as building blocks for carbonic anhydrase inhibitors. Metabolites 2018;8:1–22.
   Web of Science ®Google Scholar
• Moree WJ, Van Der Marel GA, Liskamp RJ. Synthesis of peptidosulfinamides and peptidosulfonamides: peptidomimetics containing the sulfinamide or sulfonamide. J Org Chem 1995;60:5157–69.
   Web of Science ®Google Scholar
• Nocentini A, Supuran CT. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opin Drug Discov 2019;14:1175–97.
   PubMed Web of Science ®Google Scholar
• Küçükbay FZ, Küçükbay H, Tanc M, Supuran CT. Synthesis and carbonic anhydrase I, II, IV and XII inhibitory properties of N-protected amino acid – sulfonamide conjugates. J Enzyme Inhib Med Chem 2016;31:1476–83.
   PubMed Web of Science ®Google Scholar
• Buğday N, Küçükbay FZ, Küçükbay H, et al. Synthesis of novel dipeptide sulfonamide conjugates with effective carbonic anhydrase I, II, IX, and XII inhibitory properties. Bioorg Chem 2018;81:311–8.
   PubMed Web of Science ®Google Scholar
• Küçükbay H, Buğday N, Küçükbay FZ, et al. Bioorganic chemistry synthesis and carbonic anhydrase inhibitory properties of novel 4-(2-aminoethyl) benzenesulfonamide-dipeptide conjugates. Bioorg Chem 2019;83:414–23.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Capasso C. An overview of the bacterial carbonic anhydrases. Metabolites 2017;7:56.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
   PubMed Web of Science ®Google Scholar
• Sagar NR, Durgamma S, Srinivasulu C, et al. A unified approach to access N-acyl sulfonamide tethered peptide conjugates. ChemistrySelect 2019;4:6408–13.
   Web of Science ®Google Scholar
• Küçükbay FZ, Buğday N, Küçükbay H, et al. Synthesis, characterization and carbonic anhydrase inhibitory activity of novel benzothiazole derivatives. J Enzyme Inh Med Chem 2016;31:1221–5.
   PubMed Web of Science ®Google Scholar
• Buǧday N, Küçükbay FZ, Apohan E, et al. Synthesis and evaluation of novel benzimidazole conjugates incorporating amino acids and dipeptide moieties. Lett Org Chem 2017;14:198–206.
   Web of Science ®Google Scholar
• Küçükbay FZ, Küçükbay H, Tanc M, Supuran CT. Synthesis and carbonic anhydrase inhibitory properties of amino acid – coumarin/quinolinone conjugates incorporating glycine, alanine and phenylalanine moieties. J Enzyme Inhib Med Chem 2016;31:1198–202.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Mincione F, Starnotti M, Menabuoni L, et al. Carbonic anhydrase inhibitors: 4-Sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties. Bioorganic Med Chem Lett 2001;11:1787–91.
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, De Luca V, et al. Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis. J Enzyme Inhib Med Chem 2015;30:366–70.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorganic Med Chem 2007;15:4336–50.
   PubMed Web of Science ®Google Scholar
• Maresca A, Vullo D, Scozzafava A, et al. Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids. J Enzyme Inhib Med Chem 2013;28:392–6.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Passaponti M, Supuran CT, Gülçin I. Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII). J Enzyme Inhib Med Chem 2015;30:586–91.
   PubMed Web of Science ®Google Scholar
• Katritzky AR, Angrish P, Narindoshvili T. Chiral O-(Z-alpha-aminoacyl) sugars: convenient building blocks for glycopeptide libraries. Bioconjug Chem 2007;18:2202–3.
   Web of Science ®Google Scholar
• Katritzky AR, El-Nachef C, Bajaj K, et al. Efficient syntheses of thiadiazole peptides. J Org Chem 2010;75:6009–11.
   PubMed Web of Science ®Google Scholar
• Katritzky AR, Avan I, Tala SR, Steel PJ. Benzotriazole-mediated syntheses of depsipeptides and oligoesters. J Org Chem 2011;76:4884–93.
   PubMed Web of Science ®Google Scholar
• Panda SS, Ibrahim MA, Küçükbay H, et al. Synthesis and antimalarial bioassay of quinine - peptide conjugates. Chem Biol Drug Des 2013;82:361–6.
   PubMed Web of Science ®Google Scholar
• Ibrahim MA, Panda SS, Oliferenko AA, et al. Macrocyclic peptidomimetics with antimicrobial activity: synthesis, bioassay, and molecular modeling studies. Org Biomol Chem 2015;13:9492–503.
   PubMed Web of Science ®Google Scholar
• Katritzky AR, Suzuki K, Singh SK. Highly diastereoselective peptide chain extensions of unprotected amino acids with N-(Z-α-aminoacyl)benzotriazoles. Synthesis 2004;5:2645–52.
   Web of Science ®Google Scholar
• Bajaj K, Panda SS, El-Nachef C, Katritzky AR. Syntheses of chiral N-(protected) tri- and tetrapeptide conjugates. Chem Biol Drug Des 2012;80:17–26.
   PubMed Web of Science ®Google Scholar
• Panda SS, Hall CD, Scriven E, Katritzky AR. Aminoacyl benzotriazolides: versatile reagents for the preparation of peptides and their mimetics and conjugates. Aldrichimica Act 2013;46:43–58.
   Web of Science ®Google Scholar
• Elagawany M, Ibrahim MA, Panda SS. One-pot synthesis of bi- and tricyclic heterocyclic compounds using benzotriazole chemistry. Tetrahedron Lett 2016;57:4910–3.
   Web of Science ®Google Scholar
• Albers T, Watkins D, Gameiro AF, et al. Benzotriazole-based strategies toward peptidomimetics, conjugates, and other peptide derivatives In: Monbaliu JCM, ed. The chemistry of benzotriazole derivatives. Vol. 43: Cham: Springer International Publishing; 2016:95–141.
   Google Scholar
• Köhler K, Hillebrecht A, Schulze Wischeler J, et al. Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste. Angew Chem Int Ed Engl 2007;46:7697–9.
   PubMed Web of Science ®Google Scholar
• Akocak S, Lolak N, Bua S, Supuran CT. Discovery of novel 1, 3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors. J Enzyme Inhib Med Chem 2018;33:1575–80.
   PubMed Web of Science ®Google Scholar
• De Simone G, Supuran CT. (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 2012;111:117–29.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Ilies MA, Scozzafava A. Carbonic anhydrase inhibitors. Part 29. Interaction of isozymes I, II and IV with benzolamide-like derivatives. Eur J Med Chem 1998;33:739–52.
   Web of Science ®Google Scholar
• Tars K, Vullo D, Kazaks A, et al. Sulfocoumarins (1,2-benzoxathiine 2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem 2013;56:293–300.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Menabuoni L, Mincione F, et al. Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action. J Med Chem 2000;43:4542–51.
   PubMed Web of Science ®Google Scholar
• Sentürk M, Gülçin I, Daştan A, et al. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem 2009;17:3207–11.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Briganti F, Mincione G, et al. Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route. J Med Chem 1999;42:3690–700.
   PubMed Web of Science ®Google Scholar
• Sarikaya SBÖ, Topal F, Şentürk M, et al. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds. Bioorg Med Chem Lett 2011;21:4259–62.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Clare BW. Carbonic anhydrase inhibitors. Part 57. Quantum chemical QSAR of a group of 1,3,4-thiadiazole and 1,3,4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties. Eur J Med Chem 1999;34:41–50.
   Web of Science ®Google Scholar
• Supuran CT, Nicolae A, Popescu A. Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes. Eur J Med Chem 1996;31:431–8.
   Web of Science ®Google Scholar